vs

Side-by-side financial comparison of SAUL CENTERS, INC. (BFS) and MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI). Click either name above to swap in a different company.

SAUL CENTERS, INC. is the larger business by last-quarter revenue ($75.1M vs $49.9M, roughly 1.5× MARAVAI LIFESCIENCES HOLDINGS, INC.). SAUL CENTERS, INC. runs the higher net margin — 8.7% vs -71.6%, a 80.2% gap on every dollar of revenue. On growth, SAUL CENTERS, INC. posted the faster year-over-year revenue change (10.6% vs -11.8%). Over the past eight quarters, SAUL CENTERS, INC.'s revenue compounded faster (6.2% CAGR vs -11.9%).

Saul Centers, Inc. is a self-administered real estate investment trust (REIT) headquartered in the United States. It primarily owns, operates, and develops high-quality shopping centers, mixed-use properties, and multifamily residential assets, with its core portfolio concentrated in the Washington D.C. metropolitan area and other select high-growth U.S. regional markets.

Maravai LifeSciences Holdings is a global life sciences firm developing critical reagents, diagnostic products, and tech solutions to support biopharma research, drug development, clinical diagnostics, and cell/gene therapy manufacturing. It serves biotech, pharma, research bodies and labs worldwide across three core segments.

BFS vs MRVI — Head-to-Head

Bigger by revenue
BFS
BFS
1.5× larger
BFS
$75.1M
$49.9M
MRVI
Growing faster (revenue YoY)
BFS
BFS
+22.5% gap
BFS
10.6%
-11.8%
MRVI
Higher net margin
BFS
BFS
80.2% more per $
BFS
8.7%
-71.6%
MRVI
Faster 2-yr revenue CAGR
BFS
BFS
Annualised
BFS
6.2%
-11.9%
MRVI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BFS
BFS
MRVI
MRVI
Revenue
$75.1M
$49.9M
Net Profit
$6.5M
$-35.7M
Gross Margin
25.8%
Operating Margin
65.4%
-117.9%
Net Margin
8.7%
-71.6%
Revenue YoY
10.6%
-11.8%
Net Profit YoY
-19.6%
-37.7%
EPS (diluted)
$0.15
$-0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BFS
BFS
MRVI
MRVI
Q4 25
$75.1M
$49.9M
Q3 25
$72.0M
$41.6M
Q2 25
$70.8M
$47.4M
Q1 25
$71.9M
$46.9M
Q4 24
$67.9M
$56.6M
Q3 24
$67.3M
$69.0M
Q2 24
$66.9M
$69.4M
Q1 24
$66.7M
$64.2M
Net Profit
BFS
BFS
MRVI
MRVI
Q4 25
$6.5M
$-35.7M
Q3 25
$10.5M
$-25.6M
Q2 25
$10.7M
$-39.6M
Q1 25
$9.8M
$-29.9M
Q4 24
$8.1M
$-25.9M
Q3 24
$14.5M
$-97.1M
Q2 24
$14.4M
$-9.8M
Q1 24
$13.6M
$-12.1M
Gross Margin
BFS
BFS
MRVI
MRVI
Q4 25
25.8%
Q3 25
13.6%
Q2 25
16.4%
Q1 25
16.5%
Q4 24
34.3%
Q3 24
73.6%
46.7%
Q2 24
74.2%
44.4%
Q1 24
72.8%
40.3%
Operating Margin
BFS
BFS
MRVI
MRVI
Q4 25
65.4%
-117.9%
Q3 25
69.1%
-98.6%
Q2 25
68.7%
-139.8%
Q1 25
66.5%
-104.9%
Q4 24
82.9%
-66.7%
Q3 24
72.8%
-239.9%
Q2 24
75.0%
-19.4%
Q1 24
72.4%
-29.4%
Net Margin
BFS
BFS
MRVI
MRVI
Q4 25
8.7%
-71.6%
Q3 25
14.6%
-61.4%
Q2 25
15.1%
-83.5%
Q1 25
13.6%
-63.9%
Q4 24
11.9%
-45.8%
Q3 24
21.5%
-140.6%
Q2 24
21.6%
-14.1%
Q1 24
20.4%
-18.8%
EPS (diluted)
BFS
BFS
MRVI
MRVI
Q4 25
$0.15
$-0.24
Q3 25
$0.32
$-0.18
Q2 25
$0.33
$-0.27
Q1 25
$0.29
$-0.21
Q4 24
$0.22
$-0.21
Q3 24
$0.48
$-0.68
Q2 24
$0.48
$-0.07
Q1 24
$0.45
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BFS
BFS
MRVI
MRVI
Cash + ST InvestmentsLiquidity on hand
$8.7M
$216.9M
Total DebtLower is stronger
$468.4M
$291.8M
Stockholders' EquityBook value
$307.8M
$212.4M
Total Assets
$2.2B
$770.6M
Debt / EquityLower = less leverage
1.52×
1.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BFS
BFS
MRVI
MRVI
Q4 25
$8.7M
$216.9M
Q3 25
$11.8M
$243.6M
Q2 25
$5.3M
$269.9M
Q1 25
$6.5M
$285.1M
Q4 24
$10.3M
$322.4M
Q3 24
$7.2M
$578.2M
Q2 24
$6.9M
$573.2M
Q1 24
$7.1M
$561.7M
Total Debt
BFS
BFS
MRVI
MRVI
Q4 25
$468.4M
$291.8M
Q3 25
$1.6B
$292.8M
Q2 25
$1.6B
$293.9M
Q1 25
$1.5B
$294.9M
Q4 24
$455.8M
$295.9M
Q3 24
$1.5B
$521.7M
Q2 24
$1.4B
$522.5M
Q1 24
$1.4B
$523.3M
Stockholders' Equity
BFS
BFS
MRVI
MRVI
Q4 25
$307.8M
$212.4M
Q3 25
$316.6M
$245.4M
Q2 25
$322.4M
$265.9M
Q1 25
$328.4M
$300.6M
Q4 24
$335.8M
$325.3M
Q3 24
$341.8M
$344.9M
Q2 24
$345.7M
$434.7M
Q1 24
$347.1M
$410.7M
Total Assets
BFS
BFS
MRVI
MRVI
Q4 25
$2.2B
$770.6M
Q3 25
$2.2B
$849.2M
Q2 25
$2.1B
$897.0M
Q1 25
$2.1B
$959.8M
Q4 24
$2.1B
$1.0B
Q3 24
$2.1B
$1.3B
Q2 24
$2.1B
$1.4B
Q1 24
$2.0B
$1.4B
Debt / Equity
BFS
BFS
MRVI
MRVI
Q4 25
1.52×
1.37×
Q3 25
5.02×
1.19×
Q2 25
4.85×
1.11×
Q1 25
4.70×
0.98×
Q4 24
1.36×
0.91×
Q3 24
4.37×
1.51×
Q2 24
4.17×
1.20×
Q1 24
4.06×
1.27×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BFS
BFS
MRVI
MRVI
Operating Cash FlowLast quarter
$99.8M
$-22.8M
Free Cash FlowOCF − Capex
$-24.9M
FCF MarginFCF / Revenue
-49.9%
Capex IntensityCapex / Revenue
4.2%
Cash ConversionOCF / Net Profit
15.35×
TTM Free Cash FlowTrailing 4 quarters
$-70.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BFS
BFS
MRVI
MRVI
Q4 25
$99.8M
$-22.8M
Q3 25
$20.6M
$-15.2M
Q2 25
$26.6M
$-10.3M
Q1 25
$30.4M
$-9.4M
Q4 24
$121.2M
$-14.6M
Q3 24
$26.5M
$13.1M
Q2 24
$32.1M
$17.4M
Q1 24
$33.8M
$-8.5M
Free Cash Flow
BFS
BFS
MRVI
MRVI
Q4 25
$-24.9M
Q3 25
$-18.1M
Q2 25
$-13.1M
Q1 25
$-14.6M
Q4 24
$-20.5M
Q3 24
$-28.3M
$4.5M
Q2 24
$-12.5M
$7.9M
Q1 24
$-11.7M
$-14.1M
FCF Margin
BFS
BFS
MRVI
MRVI
Q4 25
-49.9%
Q3 25
-43.4%
Q2 25
-27.7%
Q1 25
-31.2%
Q4 24
-36.2%
Q3 24
-42.1%
6.6%
Q2 24
-18.7%
11.4%
Q1 24
-17.6%
-22.0%
Capex Intensity
BFS
BFS
MRVI
MRVI
Q4 25
4.2%
Q3 25
7.0%
Q2 25
6.1%
Q1 25
11.2%
Q4 24
10.3%
Q3 24
81.5%
12.4%
Q2 24
66.7%
13.8%
Q1 24
68.3%
8.8%
Cash Conversion
BFS
BFS
MRVI
MRVI
Q4 25
15.35×
Q3 25
1.97×
Q2 25
2.48×
Q1 25
3.10×
Q4 24
14.98×
Q3 24
1.83×
Q2 24
2.22×
Q1 24
2.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BFS
BFS

Segment breakdown not available.

MRVI
MRVI

Cygnus Segment$27.2M54%
Other$18.4M37%
Shipping And Handling$4.3M9%

Related Comparisons